Disease: Fallopian tube cancer
- A Cellular atlas of the human fallopian tube reveals the metamorphosis of secretory epithelial cells during the menstrual cycle and menopause
- A Perspective Review: Analyzing Collagen Alterations in Ovarian Cancer by High-Resolution Optical Microscopy
- A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRalpha-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
- A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
- A rare case of infection and spontaneous rupture in ovarian mucinous cystadenoma
- A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers
- A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine
- A Review: Biomechanical Aspects of the Fallopian Tube Relevant to its Function in Fertility
- Added value of regional <sup>18</sup>F-FDG PET/MRI-assisted whole-body <sup>18</sup>F-FDG PET/CT in malignant ascites with unknown primary origin
- AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial
- An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA t
- An Unusual Presentation: High-Grade Serous Carcinoma of the Fallopian Tube Manifesting With Altered Mental Status Secondary to a Single Brain Metastasis-A Case Report and Review of the Literature
- Anatomy, Abdomen and Pelvis: Fallopian Tube
- Aneuploidy Landscape in Precursors of Ovarian Cancer
- ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer
- Assessment of Fallopian Tube Epithelium Features Derived from Induced Pluripotent Stem Cells of Both Fallopian Tube and Skin Origins
- Bevacizumab
- Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer
- Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
- Bowel perforation with generalised peritonitis secondary to recurrent primary fallopian tube carcinoma after 17 years
- BRCA1/2 reversion mutations in a pan-cancer cohort
- Building an Efficient Peritoneal Surface Malignancies Program Despite the Lower-Middle-Income Barriers: Ukraine Experience
- Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
- CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR
- Case report: diagnosis and treatment of advanced high-grade serous ovarian carcinoma aided by <sup>68</sup>Ga-FAPI PET/MR scan
- Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer
- Clinical outcomes following identification of an incidental p53 signature in the fallopian tube
- Complicated pancreatic fistula after gynecologic surgery for left fallopian tube carcinosarcoma: A case report
- Comprehensive analysis and immunohistochemistry localization of NRP1 expression in pancancer and normal individual tissues in relation to SARS‑CoV‑2 susceptibility
- Correction: Randomised phase II trial of weekly ixabepilone biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
- Correlation between gynecological tumors and atherosclerotic diseases
- Crucial computed tomography and magnetic resonance imaging findings of fallopian tubal tuberculosis for diagnosis: a retrospective study of 26 cases
- Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico
- Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma
- Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance
- Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review
- Early-stage serous fallopian tube carcinoma
- Ectopic adrenal tissue in the mesosalpinx of an older female: the fourth case report in the literature
- Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database
- Fallopian tube single cell analysis reveals myeloid cell alterations in high-grade serous ovarian cancer
- Follicular fluid aids cell adhesion, spreading in an age independent manner and shows an age-dependent effect on DNA damage in fallopian tube epithelial cells
- Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing
- Genomic Catastrophe (Chromothripsis and Polyploidy) Correlates With Tumor Distribution in Extrauterine High-grade Serous Carcinoma
- Global epidemiology of epithelial ovarian cancer
- Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study
- High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report
- Histopathologic and Preneoplastic Changes in Tubal Ligation Materials
- Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro
- Identification of fallopian tube microbiota and its association with ovarian cancer
- Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma
- Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants
- Increase in creatinine levels associated with niraparib maintenance therapy in ovarian cancer
- Inguinal Lymph Node Metastasis as Sole Manifestation of Ovarian / Fallopian Tube Cancer: a Review of the Literature
- Interstitial lung disease caused by niraparib in ovarian cancer patient: a case report and literature review
- Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery
- Laparoscopic Splenectomy for Metachronous Splenic Metastasis of Fallopian Tube Cancer with Synchronous Rectal Metastasis-A Case Report
- Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level
- Lymphadenectomy and optimal excise lymph nodes count for early-stage primary fallopian tube cancer: a SEER-based study
- MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer
- Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
- Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium
- Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions
- Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo
- MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model
- Natural Killer Cell Dysfunction in Premenopausal <em>BRCA1</em> Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
- No Racial Disparities Observed Using Point-of-Care Genetic Counseling and Testing for Endometrial and Ovarian Cancer in a Diverse Patient Population: A Retrospective Cohort Study
- Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
- Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study
- Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs
- Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series
- Peritoneal Recurrence of Squamous Cell Carcinoma in a Young Woman After Conization for Microinvasive Cervical Cancer
- Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRalpha)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer
- Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer
- Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
- Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health
- Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial
- Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report
- Primary fallopian tube endometroid carcinoma: A rare case report
- Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline <em>BRCA2</em> Pathogenic Variant: Case Report
- Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report
- Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125
- Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer
- Rare Metastasis of Esophageal Adenocarcinoma to the Female Reproductive Tract
- Rare non-serous fallopian tube cancers: institutional experience and literature review
- Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis
- Rationale and Methodologic Approach for Assessing Ovarian Cancer Treatment and Gynecologic Oncologist Involvement in the Midwest Region of the United States
- Retroperitoneal Hematoma as an Atypical Presentation of Choriocarcinoma: A Case Report
- Revolutionizing the female reproductive system research using microfluidic chip platform
- Salpingectomy for ectopic pregnancy reduces ovarian cancer risk-a nation-wide study
- Salpingectomy for ovarian cancer prevention: Video education for the surgeon
- Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With <em>BRCA</em>-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial
- Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial
- Small-cell neuroendocrine carcinoma of the female genital tract: A comprehensive overview
- Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer
- Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression
- The Incidental Diagnosis of Adenomatoid Tumour on Fallopian Tubes Submitted for Tubal Ligation at a Tertiary Laboratory in Northern Pretoria, South Africa
- The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma
- The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer
- Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction
- Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysis